Unicycive Therapeutics annual capital expenditures (capex)
2021
2022
2023
2024
2025
Unicycive Therapeutics Capital Expenditures (CapEx) Growth & History (UNCY)
Unicycive Therapeutics's capital expenditures (capex) was $24,000 for fiscal 2025.
View full Unicycive Therapeutics company overviewUnicycive Therapeutics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $24,000 | −$48,000 | −66.67% |
| 2024 | 2024-12-31 | $72,000 | $60,000 | +500.00% |
| 2023 | 2023-12-31 | $12,000 | $10,000 | +500.00% |
| 2022 | 2022-12-31 | $2,000 | −$27,000 | −93.10% |
| 2021 | 2021-12-31 | $29,000 | — | — |
Unicycive Therapeutics quarterly capital expenditures (capex)
Q1.22
Q2.22
Q3.22
Q4.22
Q3.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1,000 | −$5,000 | −83.33% |
| Q1 2026 | 2026-03-31 | $8,000 | −$8,000 | −50.00% |
| Q4 2025 | 2025-12-31 | $0 | −$22,000 | — |
| Q3 2025 | 2025-09-30 | $2,000 | −$22,000 | −91.67% |
| Q2 2025 | 2025-06-30 | $6,000 | −$14,000 | −70.00% |
| Q1 2025 | 2025-03-31 | $16,000 | $10,000 | +166.67% |
| Q4 2024 | 2024-12-31 | $22,000 | — | — |
| Q3 2024 | 2024-09-30 | $24,000 | $24,000 | — |
| Q2 2024 | 2024-06-30 | $20,000 | — | — |
| Q1 2024 | 2024-03-31 | $6,000 | — | — |
| Q3 2023 | 2023-09-30 | $0 | $0 | — |
| Q4 2022 | 2022-12-31 | $0 | — | — |
| Q3 2022 | 2022-09-30 | $0 | — | — |
| Q2 2022 | 2022-06-30 | $0 | — | — |
| Q1 2022 | 2022-03-31 | $2,000 | — | — |
Unicycive Therapeutics capital expenditures (capex) trends
Between the periods ended 2021-12-31 and 2025-12-31, Unicycive Therapeutics's capital expenditures (capex) decreased from $29,000 to $24,000, a change of −$5,000. The latest reported quarter, Q2 2026, shows $1,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Unicycive Therapeutics source filings ↗